Advertisement

Clinical Rheumatology

, Volume 37, Issue 6, pp 1441–1448 | Cite as

Autoimmune/inflammatory syndrome induced by mineral oil: a health problem

  • Olga Vera-Lastra
  • Gabriela Medina
  • María Pilar Cruz-Domínguez
  • Gabriel Medrano Ramírez
  • Raymundo Benjamin Priego Blancas
  • Ana Lilia Peralta Amaro
  • Anabel Villanueva Martínez
  • Jesús Sepúlveda Delgado
  • Luis J. Jara
Review Article

Abstract

Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) includes the following conditions: siliconosis, Gulf War syndrome, macrophagic myofasciitis syndrome, and post-vaccination phenomena. Afterward, other syndromes have been recognized, such as in ASIA by mineral oil (ASIA-MO). These conditions are triggered by adjuvants and they are the result of the interplay of genetic and environmental factors. ASIA-MO is defined as the infiltration of oily type modeling substances for cosmetic purposes. It has been reported in many countries and used surreptitiously. Pathogenesis of ASIA-MO is not clear, but is characterized by chronic granulomatous inflammation, like the pristane model in mice, with increase of proinflammatory cytokines: type I interferons (IFNα and IFNß), systemic lupus erythematosus (SLE), and erosive arthritis. In humans, an increase of interleukin 1 (IL-1) has been found. Clinical spectrum of ASIA-MO is heterogeneous, varying from mild to severe and being local and systemic. The systemic manifestations can be non-specific and specific, meeting criteria for any autoimmune disease (AID), i.e., SLE, rheumatoid arthritis, and systemic sclerosis, among others. The areas of the body where the mineral oil is mostly applied include the following: buttocks (38–72%), breasts (12–16%), lower extremities (18–22%), and face (6–10%). The penis augmentation is also common. Treatment is focused on local and systemic manifestations and requires medical and surgical management representing a challenge for the physician.

Keywords

ASIA Clinical manifestations Diagnosis approach Epidemiology Mineral oil Treatment 

Notes

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Shoenfeld Y, Agmon-Levin N (2011) ASIA—autoimmune/inflammatory syndrome induced by adjuvant. J Autoimmun 36:4–8CrossRefPubMedGoogle Scholar
  2. 2.
    Vera-Lastra O, Medina G, Cruz-Dominguez M del P, Cruz-Dominguez MP, Ramirez P, Gayosso-Rivera JA, Anduaga-Dominguez H, Lievana-Torres C, Jara LJ (2012) Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld’s syndrome). Lupus 21:128–135CrossRefPubMedGoogle Scholar
  3. 3.
    Kumagai Y, Abe C, Shiokawa Y (1979) Scleroderma after cosmetic surgery: four cases of human adjuvant disease. Arthritis Rheum 22:532–537CrossRefPubMedGoogle Scholar
  4. 4.
    Peters W, Fornasier V (2009) Complications from injectable materials used for breast augmentation. Can J Plast Surg 17:89–96CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Petry T, Bury D, Fautz R et al (2017) Review of data on the dermal penetration of mineral oils and waxes used in cosmetic applications. Toxicol Lett 280:70–78CrossRefPubMedGoogle Scholar
  6. 6.
    Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity. Lupus 18:1217–1225CrossRefPubMedGoogle Scholar
  7. 7.
    Kimber I, Dearman RJ (2010) An assessment of the ability of phthalates to influence immune and allergic responses. Toxicology 271:73–82CrossRefPubMedGoogle Scholar
  8. 8.
    Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L (2009) Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 30:455–464CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Vera-Lastra O, Medina G, Cruz-Dominguez MDP, Jara LJ, Shoenfeld Y (2013) Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol 9:361–373CrossRefPubMedGoogle Scholar
  10. 10.
    Kumagai Y, Shiokawa Y, Medsger TA Jr et al (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 27:1–12CrossRefPubMedGoogle Scholar
  11. 11.
    Jara LJ, García-Collinot G, Medina G et al (2017) Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld’s syndrome). Immunol Res 65:8–16CrossRefPubMedGoogle Scholar
  12. 12.
    Ortiz-Monasterio F, Trigos I (1972) Management of patients with complications from injections of foreign materials into the breasts. Plast Reconstr Surg 50:42–47CrossRefPubMedGoogle Scholar
  13. 13.
    Martínez-Villarreal AA, Asz-Sigall D, Gutiérrez-Mendoza D, Serena TE, Lozano-Platonoff A, Sanchez-Cruz LY, Toussaint-Caire S, Domínguez-Cherit J, López-García LA, Cárdenas-Sánchez A, Contreras-Ruiz J (2017) A case series and a review of the literature on foreign modelling agent reaction: an emerging problem. Int Wound J 14:546–554CrossRefPubMedGoogle Scholar
  14. 14.
    Inn FX, Imran FH, Ali MF, Ih R, Z Z (2012) Penile augmentation with resultant foreign material granuloma and sequalae. Malays J Med Sci 19:81–83PubMedPubMedCentralGoogle Scholar
  15. 15.
    Moon DG, Yoo JW, Bae JH, Han CS, Kim YK, Kim JJ (2003) Sexual function and psychological characteristics of penile paraffinoma. Asian J Androl 5:191–194PubMedGoogle Scholar
  16. 16.
    Svensøy JN, Travers V, Osther PJS (2018) Complications of penile self-injections: investigation of 680 patients with complications following penile self-injections with mineral oil. World J Urol 36:135–143CrossRefPubMedGoogle Scholar
  17. 17.
    Koppang EO, Bjerkås I, Haugarvoll E et al (2008) Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol 181:4807–4814CrossRefPubMedGoogle Scholar
  18. 18.
    Kuroda Y, Akaogi J, Nacionales DC, Wasdo SC, Szabo NJ, Reeves WH, Satoh M (2004) Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci 78:222–228CrossRefPubMedGoogle Scholar
  19. 19.
    Cabral AR, Alcocer-Varela J, Orozco Topete R et al (1994) Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Rev Investig Clin 46:257–266Google Scholar
  20. 20.
    Yau ACY, Lönnblom E, Zhong J et al (2017) Influence of hydrocarbon oil structure on adjuvanticity and autoimmunity. Sci Rep 7(1):14998.  https://doi.org/10.1038/s41598-017-15096-z CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Medrano Ramírez G, García León ML, Priego Blancas R et al (2016) Función de la respuesta Th1/Th 17 en los pacientes con enfermedad humana por aplicación de substancias modeladoras. Reumatol Clin. 2016; 12 Ext 1 (abst):55Google Scholar
  22. 22.
    Speil C, Rzepka R (2011) Vaccines and vaccine adjuvants as biological response modifers. Infect Dis Clin N Am 25:755–772CrossRefGoogle Scholar
  23. 23.
    Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y (2013) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 47:1–16CrossRefPubMedGoogle Scholar
  24. 24.
    Kozeny G, Barbato A, Bansal V et al (1984) Hypercalcemia associated with silicone-induced granulomas. N Engl J Med 311:1103–1105CrossRefPubMedGoogle Scholar
  25. 25.
    Chastre J, Bouchama A, Basset F (1983) Acute pneumonitis after sub-cutaneous injections of silicone in transsexual men. N Engl J Med 308:764–767CrossRefPubMedGoogle Scholar
  26. 26.
    Watad A, Quaresma M, Bragazzi NL, Cervera R, Tervaert JWC, Amital H, Shoenfeld Y (2018) The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol 37:483–493CrossRefPubMedGoogle Scholar
  27. 27.
    Friedmann DP, Kurian A, Fitzpatrick RE (2016) Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J Cosmet Laser Ther 18(3):170–173CrossRefPubMedGoogle Scholar
  28. 28.
    Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E (2005) Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg 29:34–48CrossRefGoogle Scholar
  29. 29.
    Alijotas-Reig J (2015) Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus 24:1012–1018CrossRefPubMedGoogle Scholar
  30. 30.
    Barker TT, Lee PY, Kelly-Scumpia KM, Weinstein JS, Nacionales DC, Kumagai Y, Akira S, Croker BP, Sobel ES, Reeves WH, Satoh M (2011) Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane. Lab Investig 91:1540–1550CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Zimmermann US, Clerici TJ (2004) The histological aspects of fillers complications. Semin Cutan Med Surg 23:241–250CrossRefPubMedGoogle Scholar
  32. 32.
    Dagan A, Kogan M, Shoenfeld Y, Segal G (2016) When uncommon and common coalesce: adult onset Still’s disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA). Clin Rheumatol 35:1643–1648CrossRefPubMedGoogle Scholar
  33. 33.
    Colaris MJL, van der Hulst RR, Tervaert JWC (2017) Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature. Clin Rheumatol 36:981–993CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ma Z, Li Z, Shou K et al (2017) Negative pressure wound therapy: Regulating blood flow perfusion and microvessel maturation through microvascular pericytes. Int J Mol Med 40(5):1415–1425.  https://doi.org/10.3892/ijmm.2017.3131 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Ho WS, Chan CW, BKB L (2001) Management of paraffinoma of the breast: 10 years’ experience. Br J Plast 54:232–234CrossRefGoogle Scholar
  36. 36.
    Priego-Blancas R, Rincón-Lozano R, Serrano A et al (2010) Clasificación y tratamiento de la enfermedad mamaria por modelantes. Cir Plast 20:112–119Google Scholar
  37. 37.
    Champaneria MC, Wong WW, Hill ME, Gupta SC (2012) The evolution of breast reconstruction: a historical perspective. World J Surg 36:730–742CrossRefPubMedGoogle Scholar
  38. 38.
    Fodor L, Bota IO, Filip CI, Grecea D, Fodor M, Dindelegan G, Motocu R, Ciuce C (2011) New trends in breast reconstruction. Chirurgia (Bucur) 106:485–489Google Scholar
  39. 39.
    Frank SJ, Flusberg M, Friedman S, Sternschein M, Wolf EL, Stein MW (2014) Aesthetic surgery of the buttocks: imaging appearance. Skelet Radiol 43:133–139CrossRefGoogle Scholar
  40. 40.
    Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Itoh S (2002) Perforator flaps in lower extremity reconstruction. Handchir Mikrochir Plast Chir 34:251–256CrossRefPubMedGoogle Scholar
  41. 41.
    Bassetto F, Abatangelo S, Masetto L, Vindigni V (2012) Ultrasound-assisted liposuction as a safe and effective method for the removal of siliconomas. Aesthet Plast Surg 36:220–222CrossRefGoogle Scholar
  42. 42.
    Salgado CJ, Sinha VR, Desai U (2014) Liposuction and lipofilling for treatment of symptomatic silicone toxicosis of the gluteal region. Aesthetic Surg J 34:571–577CrossRefGoogle Scholar
  43. 43.
    Hazani R, Engineer N (2008) Surreptitious injection of mineral oil: a case report of sclerosing lipogranulomatosis. Ann Plast Surg 61:555–558CrossRefPubMedGoogle Scholar
  44. 44.
    Novo RC, Salgado CJ, Yim E, Sinha V, Chim HW, Romanelli P (2016) A staging system for gluteal foreign body reaction to injectables. J Plast Reconstr Aesthet Surg 69:e174–e179CrossRefPubMedGoogle Scholar
  45. 45.
    Lee JM, Kim JY (2015) Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg 42:232–239CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    De Gado F, Mazzocchi M, Chiummariello S et al (2006) Johnson’s baby oil, a new type of filler? Acta Chir Plast 48:123–126PubMedGoogle Scholar
  47. 47.
    Glicenstein J (2007) The first “fillers”, vaseline and paraffin. From miracle to disaster. Ann Chir Plast Esthet 52:157–161CrossRefPubMedGoogle Scholar
  48. 48.
    Manny T, Pettus J, Hemal A, Marks M, Mirzazadeh M (2011) Penile sclerosing lipogranulomas and disfigurement from use of “1Super Extenze” among Laotian immigrants. J Sex Med 8:3505–3510CrossRefPubMedGoogle Scholar
  49. 49.
    Oñate Celdrán J, Sanchez Rodríguez C, Tomás Ros M, González Valverde FM, Morga Egea JP, Ruiz Marín M, Valdelvira Nadal P, Jiménez López JM, Fontana Compiano LO (2012) Penile paraffinoma after subcutaneous injection of paraffin. Treatment with a two step cutaneous plasty of the penile shaft with scrotal skin. Arch Esp Urol 65:575–578PubMedGoogle Scholar
  50. 50.
    Nyirády P, Kelemen Z, Kiss A, Bánfi G, Borka K, Romics I (2008) Treatment and outcome of vaseline-induced sclerosing lipogranuloma of the penis. Urology 71:1132–1137CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  • Olga Vera-Lastra
    • 1
    • 2
  • Gabriela Medina
    • 1
    • 2
  • María Pilar Cruz-Domínguez
    • 1
    • 2
  • Gabriel Medrano Ramírez
    • 3
  • Raymundo Benjamin Priego Blancas
    • 3
  • Ana Lilia Peralta Amaro
    • 1
    • 2
  • Anabel Villanueva Martínez
    • 3
  • Jesús Sepúlveda Delgado
    • 4
  • Luis J. Jara
    • 1
    • 2
  1. 1.Unidad Médica de Alta Especiad, Hospital de Especialidades “Dr. Antonio Fraga Mouret,” Centro Médico Nacional “La Raza”Instituto Mexicano del Seguro SocialMexico CityMexico
  2. 2.División de Estudios de Posgrado, Facultad de MedicinaUniversidad Nacional Autónoma de MéxicoMexico CityMexico
  3. 3.Hospital General de México, “Dr. Eduardo Liceaga”Mexico CityMexico
  4. 4.Hospital Regional de Alta Especialidad Ciudad SaludTapachulaMexico

Personalised recommendations